Acute rhinosinusitis: A pharmacoeconomic review of antibacterial use

PharmacoEconomics

Volumn 22, Issue 13, 2004, Pages 829-837

  Wasserfallen, Jean Blaise ^a,b   Livio, Françoise ^a   Zanetti, Giorgio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Medical Direction   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CLARITHROMYCIN; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH SURVEY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOSINUSITIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; HUMANS; RHINITIS; SINUSITIS;

EID: 4644325712     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200422130-00002     Document Type: Review

References (32)

1. Gwaltney JM. Sinusitis. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998: 676-86
2. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214-9
3. Pfaller MA, Ehrhardt AF, Jones RN. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the Respiratory Surveillance Program Study: microbiology from the medical office practice environment. Am J Med 2001; 111 (9A): 4S-12S
4. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 Respiratory Surveillance Program. Am J Med 2001; 111 (9A): 19S-24S
5. De Bock GH, van Duijn NP, Dagnelie CF, et al. Nederlands Huisartsen Genootschap Standaard Sinusitis. Huisarts Wet 1993; 36: 255-7
6. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ 1997; 156: S1-S14
7. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibacterial use for acute rhinosinusitis in adults: background. Ann Emerg Med 2001; 37: 703-10
8. American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics 2001; 108: 798-808
9. Trinh N, Ngo HH. Practice variations in the management of sinusitis. J Otolaryngol 2000; 29: 211-7
10. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1996; 103: 408-14
11. Stalman W, van Essen GA, van der Graaf Y, et al. Maxillary sinusitis in adults: an evaluation of placebo-controlled double-blind trials. Fam Pract 1997; 14: 124-9
12. Gananca M, Trabulsi LR. The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo-controlled study. Curr Med Res Opin 1973; 1: 362-8
13. Norrelund N. Behandling af sinusitis i almenpraksis. En kontrolleret undersogelse over pivampicillin. Ugeskr Laeger 1978; 140: 2792-5
14. Rantanen T, Arvilomi H. Double-blind trial of doxycicline in acute maxillary sinusitis: a clinical and bacteriological study. Acta Otolaryngol Stockh 1973; 76: 58-62
15. De Ferranti SD, Ioannidis JPA, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibacterials for acute sinusitis?: a meta-analysis. BMJ 1998; 317: 632-8
16. Lindbaeck M, Hjortdahl P, Johnsen ULH. Randomised, double-blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996; 313: 325-9
17. Van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, et al. Primary-care based randomised placebo-controlled trial of antibacterial treatment in acute maxillary sinusitis. Lancet 1997; 349: 683-7
18. Stalman W, van Essen GA, Van der Graaf Y, et al. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice?: a placebo-controlled double-blind randomised doxycycline trial. Br J Gen Pract 1997; 47: 794-9
19. De Bock GH, Dekker FW, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997; 50: 881-90
20. Gehanno P, Depondt J, Barry B, et al. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis. J Antimicrobial Chemother 1990; 26: 87-91
21. Ioannidis JPA, Contopoulos-Ioannidis DG, Chew P, et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibacterials for upper respiratory tract infections. J Antimicrobial Chemother 2001; 48: 677-89
22. Williams JW, Aguilar C, Makela M, et al. Antibiotics for acute maxillary sinusitis. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002
23. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000; 123 Suppl. 1: S1-S32
24. Ioannidis JPA, Lau J. Technical report: evidence for the diagnosis ant treatment of acute uncomplicated sinusitis in children: a systematic overview. Pediatrics 2001; 108: 1-8
25. Morris P. Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002
26. Halpem M, Schmier J, Richner R, et al. Antimicrobial treatment patterns, resource utilization, and charges associated with acute sinusitis in asthma patients. Am J Health Syst Pharm 2000; 57: 875-81
27. Benninger MS, Sedory Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: summary of the agency for health care policy and research evidence-based report. Otolaryngol Head Neck Surg 2000; 122: 1-7
28. De Bock GH, van Erkel AR, Springer MP, et al. Antibiotic prescription for acute sinusitis in otherwise healthy adults: clinical cure in relation to costs. Scand J Prim Health Care 2001; 19: 58-63
29. Balk EM, Zucker DR, Engels EA, et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis. J Gen Intem Med 2001; 16: 701-11
30. Laurier C, Lachaine J, Ducharme M. Economic evaluation of antibacterials in the treatment of acute sinusitis. Pharmacoeconomics 1999; 15: 97-113
31. Pai CW, Ozcan YA, Jiang HJ. Regional variation in physician practice pattern: an examination of technical and cost efficiency for treating sinusitis. J Med Syst 2000; 24: 103-17
32. Kaiser L, Morabia A, Stalder H. Role of nasopharyngeal culture in antibacterial prescription for patients with common cold or acute sinusitis. Eur J Clin Microbiol Infect Dis 2001; 20: 445-51